SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 464.34 |
| Enterprise Value ($M) | 249.40 |
| Book Value ($M) | 423.77 |
| Book Value / Share | 5.25 |
| Price / Book | 1.10 |
| NCAV ($M) | 398.31 |
| NCAV / Share | 4.93 |
| Price / NCAV | 1.17 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.40 |
| Return on Assets (ROA) | -0.31 |
| Return on Equity (ROE) | -0.34 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 9.46 |
| Current Ratio | 9.46 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 744.83 |
| Assets | 760.16 |
| Liabilities | 346.52 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 53.88 |
| Operating Income | -193.19 |
| Net Income | -173.98 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 134.32 |
| Cash from Investing | -101.59 |
| Cash from Financing | 154.42 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | BlackRock, Inc. | 7.80 | -20.23 | |
| 13G/A | Paradigm Biocapital Advisors LP | 0.00 | -100.00 | |
| 13G | Armistice Capital, Llc | 7.46 | ||
| 13G/A | Suvretta Capital Management, Llc | 6.70 | -30.43 | |
| 13G/A | Flynn James E | 0.00 | -100.00 | |
| 13G | Biotechnology Value Fund L P | 7.50 | 40.36 | |
| 13G | Ra Capital Management, L.p. | 5.60 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 80,164 | 759,013 | 10.56 | |
| 194,708 | 1,572,285 | 12.38 | |
| 270,603 | 3,375,561 | 8.02 | |
| 264,489 | 3,874,172 | 6.83 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| KPTI – Karyopharm Therapeutics Inc. | KRON – Kronos Bio, Inc. |
| KRYS – Krystal Biotech, Inc. | KYTX – Kyverna Therapeutics, Inc. |
| LVTX – LAVA Therapeutics N.V. |
Financial data and stock pages provided by
Fintel.io